×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Clinical: GLP-1/GCG Dual Agonist LIGHT-COG (NCT07083154)
clinical
1,707 words
KG: ent-clin-c237937a
2026-03-28
kind:clinical-trial
section:clinical-trials
topic:alzheimers
topic:diabetes
topic:glp-1-agonist
topic:phase-3
Contents
GLP-1/GCG Dual Agonist LIGHT-COG (NCT07083154)
Knowledge Graph
Related Hypotheses (9)
APOE-Dependent Autophagy Restoration
Score: 0.61
Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.57
Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.51
Metabolic Switch Targeting for A1→A2 Repolarization
Score: 0.48
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.48
Metabolic Circuit Breaker via Lipid Droplet Modulation
Score: 0.48
Excitatory Neuron Vulnerability via SLC17A7 Downregulation
Score: 0.44
Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics
Score: 0.42
Trans-Synaptic Adhesion Molecule Modulation
Score: 0.34
Show 4 more
Related Analyses (4)
Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Related Experiments (9)
GLP-1 Agonist Neuroprotection Mechanism in PD
clinical · proposed · Score: 0.40
GLP-1 Agonist Responder Prediction Study — Precision Medicin
clinical · proposed · Score: 0.40
Metabolic Syndrome-Parkinson's Disease Axis Clinical Trial
clinical · proposed · Score: 0.40
Tirzepatide vs Semaglutide Anti-Atherosclerotic Effects in A
validation · proposed · Score: 0.90
AAV-LRRK2 IND-Enabling Study Design
clinical · proposed · Score: 0.40
Combination Therapy Sequencing in Parkinson's Disease
validation · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
AAV-LRRK2 Gene Therapy IND-Enabling Study Design
clinical · proposed · Score: 0.40
Neural Stem Cell Therapy for Alzheimer's Disease
clinical · proposed · Score: 0.40
Show 4 more